REVIER Therapeutics

Health Care · Cardiometabolic Therapeutics

Overview

Revier Therapeutics has established the first therapeutic approach to selectively target class IIa HDACs to treat cardiometabolic diseases. Learn more.

Funding and backers

Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2020 Founded
Registers and programsofficial lists and records that name the company
Legal entity Revier Therapeutics GmbH its site
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds fund
Investors in similar startupsfunds that back the companies most like this one
RA Capital Management
backs Verdiva Bio, PAhR Therapeutics
Jeito Capital
backs Alveus, Augustine Therapeutics
OrbiMed
backs Verdiva Bio
Omega Funds
backs Alveus
Asabys Partners
backs Augustine Therapeutics
NRW.BANK
backs Refoxy Pharmaceuticals GmbH
Similar startupsby what they do, their industry and backers
Refoxy Pharmaceuticals GmbH11-50 employees
Refoxy Pharmaceuticals GmbH is a pre-clinical biotech company developing FOXO3-targeting therapies to restore cellular balance and treat…
PAhR TherapeuticsSeed $14M · 15 mo ago
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
Augustine TherapeuticsFounded 2019 · 11-50 employees
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…
Verdiva BioSeries A $410M · 21 mo ago · 201-500 employees
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
AlveusVenture round $56.9M · 10 mo ago · Founded 2014 · 11-50 employees
At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior…
AngiolutionsVenture round · 6 mo ago · Founded 2020 · 201-500 employees
Angiolutions: the first company to develop a device to treat small abdominal aortic aneurysms (AAAs).

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
High-Tech GründerfondsVia a fund
516 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Heidelberg Germany
HQ
company site